News Archive

University of Vermont Health Network Ventures and Wilson Sonsini Goodrich & Rosati Invest in BioFactura

Funded by the Maryland Innovation Initiative Fund

Three startups received funding this week from a TEDCO fund designed to help firms founded by entrepreneurs from economically or socially disadvantaged backgrounds.

Monday the firm announced that it had agreed to be acquired by Catalent Biologics in a more than $1.2 billion deal expected to be completed this quarter.

A startup that came in at number 8 on Technical.ly DC’s 2018 realLIST just closed on its first investment round.

Home remodeling marketplace remodelmate announced today they raised a $525,000 seed round led by CoVenture and from other leading firms MIT Alumni Angels of Washington, D.C., Dorm Room Fund and TEDCO, as well as angels.

New startup founders and CEOs draw on the experiences of fellow entrepreneurs in what has been dubbed, the Founders Network.

Two Johns Hopkins University are reinventing the surgical mask to make quality health care accessible in hospitals and doctor’s offices everywhere.

F3 (Farm-Fish-Food) Tech – an initiative of the Eastern Shore Entrepreneurship Center – is now accepting applications through May 19.

Founder Debra Bond Cancro on the company's algorithms and approach: "The idea of giving people feedback about how others perceive them is what makes us really novel."

The monthly meetings of TEDCO's Women's Executive Leadership Roundtable help execs deal with business challenges — gender-specific and otherwise — alongside peers.

Ambrose talks about moving from academia to a tech company, and taking on a leadership role.

The startup is looking to offer its streaming health and fitness classes to organizations for use by employees.

Vixiar's system measures left ventricle end-diastolic volume by walking the patient through a special breathing exercise.

Vixiar Medical, Inc., a privately held Maryland company dedicated to the development of non-invasive devices and systems for monitoring cardiopulmonary diseases, announced today that it closed its most recent financing of $1.5 million from new and existing investors.